{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:32:55Z","timestamp":1790609575984,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI069453"],"award-info":[{"award-number":["UM1 AI069453"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["UM1 AI068614, UM1 AI068618"],"award-info":[{"award-number":["UM1 AI068614, UM1 AI068618"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["UM1 AI068614, UM1 AI068618"],"award-info":[{"award-number":["UM1 AI068614, UM1 AI068618"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To produce quality data that informs valid clinical trial results and withstands regulatory inspection, trial sites should adhere to many complex and dynamic requirements. Understanding non-conformance to requirements informs the emerging field of improvement science. We describe protocol deviations in South Africa\u2019s largest HIV vaccine efficacy trial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analysed data from the HVTN 702 trial using mixed methods. We obtained descriptive statistics, from protocol deviation case report forms collected from 2016\u20132022, of deviation by participant, trial site, and time to site awareness. We thematically analysed text narratives of deviation descriptions, corrective and preventive actions, generating categories, codes and themes which emerged from the data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>For 5407 enrollments, 4074 protocol deviations were reported (75 [95% CI: 73.0\u201377.6] deviations per 100 enrolments). There was a median of 1 protocol deviation per participant (IQR 1\u20132). Median time from deviation to site awareness was 31\u00a0days (IQR 0\u2013146). The most common category of deviation type was omitted data and\/or procedures (69%), and 54% of these omissions were stated to have arisen because of the national lockdown at the beginning of the COVID-19 pandemic. The ratio of protocol deviations to cumulative enrolments was highest in the year 2020 (0.34). Major themes of deviations were: COVID-19 and climate disasters giving rise to deviation trends, subroutines introducing an opportunity for deviation, and document fragmentation (such as requirements dispersed across multiple guidance documents) as an obstacle. Preventive action categories were: no preventive measures; discipline, training and\/or awareness; quality review, checking and verifying and changing the process and\/or implementation tools. Major themes of preventive actions were that systems-based actions are unusual, with people-based actions dominating, and that root cause analysis was rarely mentioned.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In the age of infectious and climate disaster risks, trials may benefit from simple study designs and trial-related documents. To optimise protocol adherence, sponsors and sites should consider ongoing training, and routinely review deviation reports with a view to adjusting processes. These data quality lessons may inform future trial design, training and implementation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>HVTN 702 was registered with the South African National Clinical Trials Register (DOH-27\u20130916-5327) and ClinicalTrials.gov (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02968849\">NCT02968849<\/jats:ext-link>).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12874-023-01967-9","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T07:01:42Z","timestamp":1687590102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Data quality in an HIV vaccine efficacy clinical trial in South Africa: through natural disasters and with discipline"],"prefix":"10.1186","volume":"23","author":[{"given":"Fatima","family":"Laher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mookho","family":"Malahleha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Brumskine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy","family":"Otwombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Moodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,24]]},"reference":[{"key":"1967_CR1","doi-asserted-by":"crossref","unstructured":"Friedman LM, Furberg CD, DeMets DL, Reboussin DM, Granger CB. Fundamentals of Clinical Trials. 5th ed. e-book: Springer, 2015, pp.233\u2013250.","DOI":"10.1007\/978-3-319-18539-2_11"},{"key":"1967_CR2","unstructured":"International Conference on Harmonisation. Efficacy guidelines. https:\/\/www.ich.org\/page\/efficacy-guidelines (Accessed 01 Jul 2022)."},{"key":"1967_CR3","unstructured":"European Medicines Agency. Classification and analysis of the GCP inspection findings of GCP inspections conducted at the request of the CHMP. https:\/\/www.ema.europa.eu\/en\/documents\/other\/classification-analysis-good-clinical-practice-gcp-inspection-findings-gcp-inspections-conducted_en.pdf (Accessed 01 Jul 2022)."},{"key":"1967_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1177\/2168479017751405","volume":"5","author":"CA Garmendia","year":"2018","unstructured":"Garmendia CA, Epnere K, Bhansali N. Research deviations in FDA-regulated clinical trials: a cross-sectional analysis of FDA inspection citations. Ther Innov Regul Sci. 2018;5:579\u201391.","journal-title":"Ther Innov Regul Sci"},{"key":"1967_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1001\/jamainternmed.2014.7774","volume":"4","author":"C Seife","year":"2015","unstructured":"Seife C. Research misconduct identified by the US Food and Drug Administration: out of sight, out of mind, out of the peer-reviewed literature. JAMA Intern Med. 2015;4:567\u201377.","journal-title":"JAMA Intern Med"},{"key":"1967_CR6","volume":"8","author":"SJ Girdler","year":"2016","unstructured":"Girdler SJ, Glezos CD, Link TM, et al. The science of quality improvement. JBJS Rev. 2016;8: e2.","journal-title":"JBJS Rev"},{"key":"1967_CR7","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s00705-020-04777-2","volume":"165","author":"F Laher","year":"2020","unstructured":"Laher F, Bekker LG, Garrett N, et al. Review of preventative HIV vaccine clinical trials in South Africa. Arch of Virol. 2020;165:2439\u201352.","journal-title":"Arch of Virol"},{"key":"1967_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2031499","volume":"12","author":"GE Gray","year":"2021","unstructured":"Gray GE, Bekker LG, Laher F, et al. Vaccine efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in adults. N Engl J Med. 2021;12:1089\u2013100.","journal-title":"N Engl J Med"},{"issue":"6","key":"1967_CR9","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1753-6405.2007.00141.x","volume":"31","author":"J Green","year":"2007","unstructured":"Green J, Willis K, Hughes E, et al. Generating best evidence from qualitative research: the role of data analysis. Aust N Z J Public Health. 2007;31(6):545\u201350.","journal-title":"Aust N Z J Public Health"},{"key":"1967_CR10","doi-asserted-by":"publisher","first-page":"101607","DOI":"10.1016\/j.ijdrr.2020.101607","volume":"49","author":"JM Lawrence","year":"2020","unstructured":"Lawrence JM, Ibne Hossain NU, Jaradat R, et al. Leveraging a Bayesian network approach to model and analyze supplier vulnerability to severe weather risk: A case study of the U.S. pharmaceutical supply chain following Hurricane Maria. Int J Disaster Risk Reduct. 2020;49:101607.","journal-title":"Int J Disaster Risk Reduct"},{"key":"1967_CR11","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1177\/1740774513491337","volume":"10","author":"E O\u2019Leary","year":"2013","unstructured":"O\u2019Leary E, Seow H, Julian J, et al. Data collection in cancer clinical trials: too much of a good thing. Clin Trials. 2013;10:624\u201332.","journal-title":"Clin Trials"},{"key":"1967_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0955-3886(99)00088-0","volume":"2","author":"TL Motschman","year":"1999","unstructured":"Motschman TL, Moore SB. Corrective and preventive action. Transfus Sci. 1999;2:163\u201378.","journal-title":"Transfus Sci"},{"key":"1967_CR13","first-page":"79","volume":"4","author":"P Spath","year":"1998","unstructured":"Spath P. Add root-cause analysis to your PI armament. Hosp Peer Rev. 1998;4:79\u201383.","journal-title":"Hosp Peer Rev"},{"key":"1967_CR14","doi-asserted-by":"publisher","unstructured":"Shah F, Falconer EA, Cimiotti JP. Does root cause analysis improve patient safety? A systematic review at the Department of Veterans Affairs. Qual Manag Health Care Epub ahead of print. 2022. https:\/\/doi.org\/10.1097\/QMH.0000000000000344.","DOI":"10.1097\/QMH.0000000000000344"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-023-01967-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-023-01967-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-023-01967-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T07:02:22Z","timestamp":1687590142000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-023-01967-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,24]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1967"],"URL":"https:\/\/doi.org\/10.1186\/s12874-023-01967-9","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,24]]},"assertion":[{"value":"22 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the University of the Witwatersrand Human Research Ethics Committee (ethics reference number: 160208B). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable \u2013 no individual data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}